Shopping Cart 0
Cart Subtotal
USD 0

Emerald Health Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Emerald Health Sciences Inc (EHS) focuses to advance the development of cannabis in pharmaceutical, botanical and bioceutical applications. The company is developing EHP-101 based on cannabidiol for the treatment of multiple sclerosis (MS) and scleroderma; and EHP-102, derived from cannabigerol for the treatment of Huntington's disease and Parkinson's disease. It also provides cannabis oil products, which include non-psychotropic THCA (Tetrahydrocannabinolic acid) oil, and THC oil. EHS develops proprietary formulations which stimulates the endocannabinoid system. The company provides products intended to treat anxiety, sleep, inflammation, pain, arthritis, and dermatitis. EHS is headquartered in North Vancouver, British Columbia, Canada.

Emerald Health Sciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Emerald Health Sciences Enters into Agreement with University of Eastern Piedmont 10

Equity Offering 11

NEMUS Bioscience Raises USD1.75 Million in Private Placement of Shares 11

Emerald Health Sciences Raises USD9.6 Million in Private Placement of Shares 12

Emerald Health Sciences to Raise USD8 Million in Private Placement Shares 13

Emerald Health Therapeutics Raises USD2.3 Million in Private Placement of Units 14

Emerald Health Therapeutics Raises USD0.6 Million in Private Placement of Units 15

Acquisition 16

Emerald Health Sciences Acquires 10% Stake in VivaCell 16

Emerald Health Sciences Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Product News 18

Sep 14, 2017: Emerald Health Pharmaceuticals to Treat Life-Threatening Diseases with Novel Synthetic Cannabinoid-Derived Molecules 18

02/06/2018: Emerald Health Pharmaceuticals' Scientific Team Publishes Evidence of Neuroprotection Using Patented Cannabinoid Derivative for Parkinson's Disease 20

Product Approvals 21

Feb 26, 2018: Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Huntington's Disease 21

Feb 15, 2018: Emerald Health Pharmaceuticals Granted European Orphan Designation for Systemic Scleroderma 22

Oct 20, 2017: Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Systemic Scleroderma 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Emerald Health Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Emerald Health Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Emerald Health Sciences Enters into Agreement with University of Eastern Piedmont 10

NEMUS Bioscience Raises USD1.75 Million in Private Placement of Shares 11

Emerald Health Sciences Raises USD9.6 Million in Private Placement of Shares 12

Emerald Health Sciences to Raise USD8 Million in Private Placement Shares 13

Emerald Health Therapeutics Raises USD2.3 Million in Private Placement of Units 14

Emerald Health Therapeutics Raises USD0.6 Million in Private Placement of Units 15

Emerald Health Sciences Acquires 10% Stake in VivaCell 16

Emerald Health Sciences Inc, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Emerald Health Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.